Selecta Biosciences Inc.

NASDAQ: SELB · Real-Time Price · USD
0.88
-0.08 (-8.12%)
At close: Nov 13, 2023, 10:00 PM

Selecta Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
180.43M 212.61M 219.2M 76.91M 79.6M 112.03M 125.92M 106.44M 112.84M 138.06M 113.44M 114.06M 114.64M 125.75M 125.41M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a 28.16M 33.6M 4M 4M 14M 24.02M 24.39M 22.41M
Long-Term Investments
2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M n/a n/a
Other Long-Term Assets
158.32M 152.79M 152.27M 151.98M 1.41M 1.41M 1.33M 1.34M 1.63M 1.43M 1.46M 1.47M 1.47M 1.53M 1.64M
Receivables
1.76M 872K 5.81M 8.85M 6.77M 6.44M 8.68M 9.76M 6.92M 23.99M 7.15M 9.91M 7.32M 8.46M 8.34M
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
2.92M 3.14M 4.13M 4.97M 3.49M 4.26M 3.79M 3.78M 6.31M n/a n/a n/a n/a n/a n/a
Total Current Assets
185.12M 216.63M 229.14M 90.73M 89.87M 122.72M 138.39M 148.14M 159.68M 172.57M 130.01M 144.44M 151.77M 166.81M 163.13M
Property-Plant & Equipment
15.53M 15.45M 23.75M 12.18M 12.76M 13.37M 13.97M 14.41M 14.96M 12.07M 12.22M 11.97M 11.92M 12.18M 11.98M
Goodwill & Intangibles
48.16M 48.16M 48.16M 48.16M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
224.01M 218.4M 226.18M 214.32M 16.16M 16.78M 17.3M 17.75M 18.59M 15.5M 15.69M 15.44M 15.39M 13.71M 13.62M
Total Assets
409.13M 435.02M 455.32M 305.05M 106.03M 139.51M 155.69M 165.89M 178.26M 188.07M 145.7M 159.88M 167.16M 180.52M 176.75M
Account Payables
2.1M 288K 517K 3.15M 375K 267K 1.06M 316K 214K 693K 264K 224K 1.59M 154K 594K
Deferred Revenue
n/a n/a n/a 2.31M 4.14M 4.23M 4.23M 593K 3.82M 15.97M 27.99M 53.88M 62.31M 75.01M 75.76M
Short-Term Debt
3.7M 2.85M 2.77M 2.17M 1.79M 11.96M 11.89M 10.08M 7.43M 4.41M 1.78M 7.01M 5.14M 3.27M 1.4M
Other Current Liabilities
9.2M 19.84M 18.12M 60.58M 13.64M 12.9M 9.35M 14.08M 12.26M 12.69M 9.21M 11.13M 26.57M 8.86M 6.85M
Total Current Liabilities
15M 22.98M 21.41M 68.21M 19.94M 29.37M 26.53M 25.08M 23.73M 33.76M 39.25M 72.25M 95.62M 87.3M 84.61M
Long-Term Debt
10.36M 11.13M 11.88M 8.79M 8.69M 22.95M 25.84M 27.84M 30.72M 30.65M 33.36M 28.27M 30.18M 32.07M 33.95M
Other Long-Term Liabilities
389.42M 391.57M 405.43M 348.29M 21.79M 30.66M 23.22M 19.14M 33.47M 26.93M 6.91M 25.42M 40.04M 40.63M 45.45M
Total Long-Term Liabilities
415.92M 418.85M 433.16M 376.47M 25.77M 44.69M 54.58M 46.98M 69.63M 64.7M 50.69M 65.11M 90.28M 97.45M 111.71M
Total Liabilities
430.92M 441.82M 454.56M 444.68M 45.7M 74.06M 81.11M 72.06M 93.36M 98.46M 89.93M 137.36M 185.89M 184.74M 196.32M
Total Debt
14.07M 13.98M 14.65M 10.96M 10.48M 34.91M 37.73M 37.92M 38.15M 35.06M 35.14M 35.28M 35.31M 35.34M 35.36M
Common Stock
3K 3K 2K 16K 15K 15K 15K 15K 15K 15K 12K 12K 12K 12K 11K
Retained Earnings
-709.78M -692.07M -681.82M -614.65M -436.99M -427.99M -416.6M -394.94M -400.83M -392.94M -401.54M -430.32M -442.56M -424.66M -429.23M
Comprehensive Income
-4.59M -4.62M -4.61M -4.6M -4.62M -4.6M -4.57M -4.56M -4.53M -4.48M -4.6M -4.57M -4.56M -4.56M -4.57M
Shareholders Equity
-21.79M -6.8M 752K -440.18M 60.33M 65.45M 74.58M 93.83M 84.91M 89.61M 55.76M 22.52M -18.73M -4.22M -19.57M
Total Investments
n/a n/a n/a 2M 2M 2M 2M 30.16M 35.6M 6M 6M 16M 26.02M 24.39M 22.41M